HPGC Renmintongtai Pharmaceutical Corp (600829) - Cash Flow Conversion Efficiency
Based on the latest financial reports, HPGC Renmintongtai Pharmaceutical Corp (600829) has a cash flow conversion efficiency ratio of -0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-187.38 Million ≈ $-27.42 Million USD) by net assets (CN¥2.99 Billion ≈ $437.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HPGC Renmintongtai Pharmaceutical Corp defensive interval ratio to measure how many days the company can operate on defensive assets alone.
HPGC Renmintongtai Pharmaceutical Corp - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how HPGC Renmintongtai Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
HPGC Renmintongtai Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of HPGC Renmintongtai Pharmaceutical Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sichuan Mingxing Electric Power Co Ltd
SHG:600101
|
0.044x |
|
Synektik S.A.
WAR:SNT
|
0.376x |
|
Cogent Communications Group Inc
NASDAQ:CCOI
|
-0.079x |
|
CEWE Stiftung & Co. KGaA
XETRA:CWC
|
-0.010x |
|
Admie Holding S.A
AT:ADMIE
|
0.048x |
|
Ardmore Shpng
NYSE:ASC
|
0.041x |
|
Manitou BF S.A.
PA:MTU
|
0.154x |
|
Fidus Investment Corp
NASDAQ:FDUS
|
0.018x |
Annual Cash Flow Conversion Efficiency for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
The table below shows the annual cash flow conversion efficiency of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see HPGC Renmintongtai Pharmaceutical Corp market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.01 Billion ≈ $441.19 Million |
CN¥299.98 Million ≈ $43.90 Million |
0.099x | +148.33% |
| 2024-12-31 | CN¥2.88 Billion ≈ $421.60 Million |
CN¥115.44 Million ≈ $16.89 Million |
0.040x | -66.89% |
| 2023-12-31 | CN¥2.75 Billion ≈ $402.61 Million |
CN¥332.99 Million ≈ $48.73 Million |
0.121x | -3.02% |
| 2022-12-31 | CN¥2.46 Billion ≈ $360.36 Million |
CN¥307.33 Million ≈ $44.97 Million |
0.125x | +217.79% |
| 2021-12-31 | CN¥2.20 Billion ≈ $321.82 Million |
CN¥-233.00 Million ≈ $-34.10 Million |
-0.106x | -2188.91% |
| 2020-12-31 | CN¥1.99 Billion ≈ $291.54 Million |
CN¥-9.22 Million ≈ $-1.35 Million |
-0.005x | +97.92% |
| 2019-12-31 | CN¥1.85 Billion ≈ $270.31 Million |
CN¥-411.60 Million ≈ $-60.23 Million |
-0.223x | -196.07% |
| 2018-12-31 | CN¥1.58 Billion ≈ $231.19 Million |
CN¥366.45 Million ≈ $53.62 Million |
0.232x | +168.84% |
| 2017-12-31 | CN¥1.61 Billion ≈ $235.89 Million |
CN¥139.07 Million ≈ $20.35 Million |
0.086x | +208.97% |
| 2016-12-31 | CN¥1.65 Billion ≈ $241.12 Million |
CN¥46.01 Million ≈ $6.73 Million |
0.028x | -88.10% |
| 2015-12-31 | CN¥1.42 Billion ≈ $208.27 Million |
CN¥333.99 Million ≈ $48.87 Million |
0.235x | +28.70% |
| 2014-12-31 | CN¥2.15 Billion ≈ $315.05 Million |
CN¥392.58 Million ≈ $57.45 Million |
0.182x | +360.00% |
| 2013-12-31 | CN¥2.26 Billion ≈ $330.33 Million |
CN¥-158.31 Million ≈ $-23.17 Million |
-0.070x | -172.98% |
| 2012-12-31 | CN¥2.31 Billion ≈ $337.41 Million |
CN¥221.57 Million ≈ $32.42 Million |
0.096x | +271.75% |
| 2011-12-31 | CN¥1.94 Billion ≈ $283.25 Million |
CN¥-108.30 Million ≈ $-15.85 Million |
-0.056x | -159.69% |
| 2010-12-31 | CN¥1.74 Billion ≈ $254.43 Million |
CN¥162.99 Million ≈ $23.85 Million |
0.094x | -65.32% |
| 2009-12-31 | CN¥1.66 Billion ≈ $242.41 Million |
CN¥447.82 Million ≈ $65.53 Million |
0.270x | +776.00% |
| 2008-12-31 | CN¥1.65 Billion ≈ $241.27 Million |
CN¥-65.93 Million ≈ $-9.65 Million |
-0.040x | -129.42% |
| 2007-12-31 | CN¥1.41 Billion ≈ $205.71 Million |
CN¥191.10 Million ≈ $27.96 Million |
0.136x | -22.95% |
| 2006-12-31 | CN¥1.08 Billion ≈ $158.53 Million |
CN¥191.13 Million ≈ $27.97 Million |
0.176x | -49.94% |
| 2005-12-31 | CN¥888.23 Million ≈ $129.98 Million |
CN¥313.04 Million ≈ $45.81 Million |
0.352x | +504.14% |
| 2004-12-31 | CN¥1.04 Billion ≈ $152.24 Million |
CN¥60.69 Million ≈ $8.88 Million |
0.058x | -54.38% |
| 2003-12-31 | CN¥560.39 Million ≈ $82.00 Million |
CN¥71.65 Million ≈ $10.48 Million |
0.128x | -47.23% |
| 2002-12-31 | CN¥526.17 Million ≈ $77.00 Million |
CN¥127.49 Million ≈ $18.66 Million |
0.242x | +720.86% |
| 2001-12-31 | CN¥501.11 Million ≈ $73.33 Million |
CN¥14.79 Million ≈ $2.16 Million |
0.030x | -77.75% |
| 2000-12-31 | CN¥466.36 Million ≈ $68.24 Million |
CN¥61.85 Million ≈ $9.05 Million |
0.133x | -3.81% |
| 1999-12-31 | CN¥422.13 Million ≈ $61.77 Million |
CN¥58.21 Million ≈ $8.52 Million |
0.138x | +44.85% |
| 1998-12-31 | CN¥430.69 Million ≈ $63.02 Million |
CN¥41.00 Million ≈ $6.00 Million |
0.095x | -- |
About HPGC Renmintongtai Pharmaceutical Corp
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosm… Read more